Procter Gamble Health Ltd vs Unjha Formulations Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Procter & Gamble Health Ltd is ₹ 5160 as of 05 May 15:30 . The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00% The p/e ratio of Unjha Formulations Ltd changed from 24 to 30.5 over 5 quarters. This represents a CAGR of 21.14% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The market cap of Unjha Formulations Ltd changed from ₹ 9.78 crore to ₹ 8.47 crore over 5 quarters. This represents a CAGR of -10.87% The revenue of Procter & Gamble Health Ltd for the Dec '25 is ₹ 378.22 crore as compare to the Sep '25 revenue of ₹ 329.87 crore. This represent the growth of 14.66% The revenue of Unjha Formulations Ltd for the Dec '25 is ₹ 4.44 crore as compare to the Sep '25 revenue of ₹ 4.35 crore. This represent the growth of 2.07% The ebitda of Procter & Gamble Health Ltd for the Dec '25 is ₹ 114.82 crore as compare to the Sep '25 ebitda of ₹ 125.22 crore. This represent the decline of -8.31% The ebitda of Unjha Formulations Ltd for the Dec '25 is ₹ 0.28 crore as compare to the Sep '25 ebitda of ₹ 0.85 crore. This represent the decline of -67.06% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 77.59 crore over 7 quarters. This represents a CAGR of 33.89% The net profit of Unjha Formulations Ltd changed from ₹ 0.22 crore to ₹ 0.24 crore over 7 quarters. This represents a CAGR of 5.10% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% The dividend payout of Unjha Formulations Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% .

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

About Unjha Formulations Ltd

Unjha Formulations Ltd was established in Jun.'87 as a partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat.
It was promoted by Shambhubhai A Patel.
The Company is a pioneer in Isabgol (Psyllium) Formulation.
The Company is in service to Isabgol (Psyllium) Ayurvedic formulation profession. The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc.
It is one of the largest manufacturers of isabgul products in India.

FAQs for the comparison of Procter & Gamble Health Ltd and Unjha Formulations Ltd

Which company has a larger market capitalization, Procter & Gamble Health Ltd or Unjha Formulations Ltd?

Market cap of Procter & Gamble Health Ltd is 8,566 Cr while Market cap of Unjha Formulations Ltd is 9 Cr

What are the key factors driving the stock performance of Procter & Gamble Health Ltd and Unjha Formulations Ltd?

The stock performance of Procter & Gamble Health Ltd and Unjha Formulations Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Procter & Gamble Health Ltd and Unjha Formulations Ltd?

As of May 5, 2026, the Procter & Gamble Health Ltd stock price is INR ₹5160.9. On the other hand, Unjha Formulations Ltd stock price is INR ₹21.5.

How do dividend payouts of Procter & Gamble Health Ltd and Unjha Formulations Ltd compare?

To compare the dividend payouts of Procter & Gamble Health Ltd and Unjha Formulations Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.